It is essential to keep up with the organizations currently funding bladder cancer research around the globe. For this reason, BLC has decided to offer its community the Bladder Cancer Funding Analyzer (BCFA). More than fifty funders from over twenty countries are represented including the United States, all of the European Union, the United Kingdom, Canada and Japan.
The BCFA enables users to conduct line-of-investigation queries (e.g., epithelial-mesenchymal transition, gemcitabine-cisplatin therapy, urinary diversion), look for funding trends and see which investigators in which countries have been the most successful in obtaining funding for a given area of bladder cancer research.
Underfunding in Bladder Cancer Research
Read about the issues facing our community and strategies for improving this situation.
Limited Funds for Bladder Cancer Research and What Can We Do About It
Joost L. Boormans and Ellen C. Zwarthoff
Bladder Cancer 2 (2016) 49–51